Financhill
Sell
42

CLDT Quote, Financials, Valuation and Earnings

Last price:
$7.21
Seasonality move :
-5.26%
Day range:
$7.20 - $7.29
52-week range:
$5.83 - $10.00
Dividend yield:
4.17%
P/E ratio:
120.00x
P/S ratio:
1.11x
P/B ratio:
0.47x
Volume:
229K
Avg. volume:
420K
1-year change:
-20.09%
Market cap:
$352.7M
Revenue:
$317.2M
EPS (TTM):
$0.06

Earnings Data

Next earnings date for CLDT
Aug 01
2025
Most recent earnings per share
-$0.01
Missed by $0.01
(May 6/2025)
Consensus Estimate
--
(May 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CLDT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/01/2025 Q2 $79.7M -- -- -- --
05/06/2025 Q1 $68.3M $68.6M -$0.01 -- --
02/26/2025 Q4 $74.6M $75.1M -$0.08 -- --
11/07/2024 Q3 $87.8M $87.2M $0.05 -- --
08/02/2024 Q2 $85.7M $86.5M $0.10 -- --
05/06/2024 Q1 $68.1M $68.4M -$0.15 -- --
02/27/2024 Q4 $70.7M $72.3M -$0.23 -- --
11/02/2023 Q3 $86.2M $86.7M $0.11 -- --
08/02/2023 Q2 $83.6M $84.5M $0.15 $0.09 $0.06
05/04/2023 Q1 $65.7M $67.6M -$0.14 -$0.17 $0.03
02/23/2023 Q4 -- $70.3M -$0.08 -- --
11/08/2022 Q3 -- $87.9M $0.21 -- --
08/03/2022 Q2 -- $81.8M $0.15 -- --
05/04/2022 Q1 -- $54.9M -$0.23 -- --
02/24/2022 Q4 -- $57.3M -$0.27 -- --
11/04/2021 Q3 -- $64.3M -$0.07 -- --
08/03/2021 Q2 -- $50.2M -$0.18 -- --
05/04/2021 Q1 -- $32.1M $0.06 -- --
02/24/2021 Q4 -- $29.6M -$0.07 -- --
10/29/2020 Q3 -- $35M -$0.38 -- --
08/05/2020 Q2 -- $20.2M -$0.57 -- --
05/11/2020 Q1 -- $60.2M -$0.59 -- --
02/26/2020 Q4 -- $74.7M -$0.05 -- --
10/31/2019 Q3 -- $90.1M $0.21 -- --
07/31/2019 Q2 -- $87.9M $0.20 -- --
05/01/2019 Q1 -- $75.7M $0.03 -- --
02/25/2019 Q4 -- $77M -$0.01 -- --
10/31/2018 Q3 -- $88.9M $0.31 -- --
08/01/2018 Q2 -- $85.4M $0.29 -- --
05/01/2018 Q1 -- $72.9M $0.06 -- --
02/26/2018 Q4 -- $68.4M $0.12 -- --
10/31/2017 Q3 -- $83M $0.36 -- --
08/02/2017 Q2 -- $79.6M $0.13 -- --
05/09/2017 Q1 -- $70.8M $0.12 -- --
02/23/2017 Q4 -- $69.3M $0.07 -- --
11/03/2016 Q3 -- $79.7M $0.35 -- --
08/03/2016 Q2 -- $78M $0.31 -- --
05/05/2016 Q1 -- $68.9M $0.08 -- --
02/24/2016 Q4 -- $67.2M $0.12 -- --
11/05/2015 Q3 -- $78.3M $0.37 -- --
08/05/2015 Q2 -- $72.4M $0.33 -- --

Chatham Lodging Trust Earnings Questions

  • How Much did Chatham Lodging Trust Generate in Revenue Last Quarter?

    Chatham Lodging Trust reported $68.6M worth of top line sales in its most recent quarter.

  • Did Chatham Lodging Trust Beat Earnings Last Quarter?

    Chatham Lodging Trust announced earnings per share of -$0.01 which represents a miss of analyst forecast a -- per share.

  • Is Chatham Lodging Trust Profitable?

    Chatham Lodging Trust reported $20.8M that represents $0.43 per share over the last quarter.

  • What is the Analyst Consensus for Chatham Lodging Trust EPS Next Year?

    Chatham Lodging Trust's earnings are forecast to decrease from -$0.08 per share to -- per share next year representing a decrease of -75%.

  • When is Chatham Lodging Trust's Earnings Date?

    Chatham Lodging Trust's next earnings date is August 1, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Bloom Energy Stock Go?
How High Will Bloom Energy Stock Go?

Bloom Energy (NYSE:BE) has seen its shares surge by more…

Is Acuity a Good Stock to Buy Now?
Is Acuity a Good Stock to Buy Now?

Acuity Brands (NYSE:AYI) is an industrial company specializing in lighting.…

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Buy
74
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
49
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
55
RGC alert for May 15

Regencell Bioscience Holdings [RGC] is up 8.9% over the past day.

Buy
71
NUTX alert for May 15

Nutex Health [NUTX] is up 26.31% over the past day.

Buy
81
EXEL alert for May 15

Exelixis [EXEL] is up 20.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock